Elos Medtech's profit up in Q1 2019.

NORDIC BUSINESS REPORT-April 24, 2019-Elos Medtech's profit up in Q1 2019

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Elos Medtech AB (STO: ELOSB) reported on Tuesday profit after tax of SEK15.3m, which corresponds to SEK1.90 per share, for the first quarter of 2019, from 1 January 2019 to 31 March 2019.

This was an increase over profit after tax of SEK7.1m, or SEK1.15 per share, in Q1 2018.

Net sales for the quarter were up to SEK189.9m, as compared with SEK155.7m in Q1 2018. This corresponds to an organic growth of 22.0%. After currency adjustments, the growth rate was 15.2%.

According to the company, sales have increased faster than its long-term goal of 10%.

...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT